StockNews.AI
LFVN
StockNews.AI
209 days

LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025

1. LifeVantage will report Q2 results on February 5, 2025. 2. A conference call for investors will be held on the same day. 3. Financial results are keenly awaited due to past performance fluctuations. 4. Investors can access a live webcast of the call. 5. LifeVantage continues to focus on nutrigenomics health products.

Earnings
+0.8%Current Return
VS
+0.55%S&P 500
$23.7801/22 04:07 PM EDTEvent Start
$23.9701/23 10:55 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

While earnings reports can influence stock prices, expectations are currently unclear. Past results have shown volatility around earnings announcements without a consistent upward or downward trend.

How important is it?

Earnings reports typically significantly influence investor behavior and stock performance. However, clarity on financial outcomes is needed for a stronger impact prediction.

Why Short Term?

The anticipated earnings report will have an immediate effect on stock prices. Historically, Q2 reports have caused short-term price movements based on results.

Related Companies

LFVNAMGNAVXL
January 22, 2025 16:05 ET  | Source: LifeVantage Corporation SALT LAKE CITY, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2024, after the stock market closes on Wednesday, February 5, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, February 19, 2025, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13750382, or (412) 317-6671 from international locations, and entering confirmation code 13750382. There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1699720&tp_key=7be42f23a0. The webcast will be archived for approximately 30 days. About LifeVantage Corporation LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com. Investor Relations Contact: Reed Anderson, ICR(646) 277-1260reed.anderson@icrinc.com

Related News